Categories: FinancialNews

Jeffrey Modell Foundation Co-Hosts Global Artificial Intelligence Meeting

NEW YORK, April 8, 2025 /PRNewswire/ — The Jeffrey Modell Foundation was honored to collaborate with Drs. Nicolas Rider, Manish Butte, and Jacques Riviere to co-host a pivotal meeting on Artificial Intelligence (AI). The second Artificial Intelligence for Primary Immunodeficiencies and Inborn Errors of Immunity meeting brought together some of the most influential minds in AI research, ethics and medicine, with more than 120 attendees from over 16 countries.

“This pivotal global meeting offered attendees the opportunity to learn more about the transformative potential of AI in supporting diagnosis and treatment of Primary Immunodeficiency (PI),” said Vanessa Tenembaum, Chief Executive Officer of the Jeffrey Model Foundation.

The meeting featured some of the world’s leading experts presenting cutting-edge research on AI as it relates to the diagnosis, treatment, and management of PI and Inborn Errors of Immunity (IEI). Key program highlights included the use of AI and Machine Learning (ML) to improve diagnosis and treatment, integration of AI into clinical decision-making, ethical considerations in AI, and opportunities for continued global collaboration.

The Foundation also introduced its groundbreaking AI tool, the Modell Mind, which leverages advanced natural language processing to simplify querying, automate complex analyses, and explore trends, patterns, and patient demographics related to PI. The Modell Mind enables efficient decision-making, offers comprehensive insights, and will transform how the Foundation analyzes PI data.

“At JMF, our mission has always been to achieve the earliest possible diagnosis, giving patients the best chance at timely and effective treatment and care. In uniting global experts, we aim to encourage cross-institutional collaborations to close the gap created by data limitations and ensure a more accurate approach to early diagnosis,” said Tenembaum.

About the Jeffrey Modell Foundation
Fred and the late Vicki Modell established the Jeffrey Modell Foundation (JMF) in 1987, in memory of their son Jeffrey, who passed away at the age of fifteen, from complications of Primary Immunodeficiency (PI) a genetic condition that is chronic, serious, and often fatal if not diagnosed correctly.

JMF is a global non-profit organization dedicated to early diagnosis, meaningful treatments and, ultimately, cures through research, physician education, public awareness, advocacy, patient support, newborn screening, and genetic sequencing. For more information visit  https://info4pi.org/ or watch Do Something: The Jeffrey Modell Story online, available in seven languages.

Media Contact:
Larissa Albright
lalbright@jmfworld.org

View original content to download multimedia:https://www.prnewswire.com/news-releases/jeffrey-modell-foundation-co-hosts-global-artificial-intelligence-meeting-302422379.html

SOURCE Jeffrey Modell Foundation

Staff

Recent Posts

Health Care AI Initiative Launched by Paragon Health Institute

New initiative will promote AI policies and solutions to transform American health careWASHINGTON, Jan. 12,…

13 minutes ago

Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound

Agreement expands Amphastar's proprietary peptide pipeline into broader inflammatory and autoimmune conditions RANCHO CUCAMONGA, CA…

13 minutes ago

CelLBxHealth PLC Announces Board Changes

GUILDFORD, SURREY / ACCESS Newswire / January 12, 2026 / CelLBxHealth plc (AIM:CLBX), a leader…

3 hours ago

Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms

Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…

4 hours ago

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

18 hours ago